Ezetimibe Tablet
Product Images NDC 16729-433

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ezetimibe (NDC 16729-433). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (30 tabs Label)

Label for Ezetimibe 10 mg tablets, USP, by Accord Healthcare Inc. The label shows the product NDC 16729-433-10 and indicates the package contains 30 tablets for oral use. Manufacturing information includes Accord Healthcare, Durham, NC, and Intas Pharmaceuticals Limited, India. Storage instructions recommend 25°C with permitted excursions.*

FDA Label Image

Image Of Ezetimibe Chemical Structure (Ezetimibe Structure)

Chemical structure diagram of ezetimibe, showing the arrangement of atoms including fluorine-substituted phenyl rings, hydroxyl groups, sulfur, and nitrogen atoms consistent with the ezetimibe molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.